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aBSTraCT
 Canine parvovirus-2 (CPV-2) infection is a serious problem causing a high rate of mortality in puppies. 
Despite the widespread vaccination of domestic dogs, a major impediment in the control of this deadly disease 
is the presence of different antigenic variants in field. Regular surveillance and constant monitoring of these 
variants, which might evade the host immune pressure and laboratory detection, is critically essential. thus, 
the present study was aimed at understanding the molecular epidemiology of CPV-2 strains circulating in 
northern region of India. Polymerase Chain reaction (PCr) positive samples were subjected to oligonucleotide 
sequencing and these isolates were found to be identical to CPV-2a except at positions 264, 297 and 440 amino 
acid residue, and thus typed as an antigenic variant of CPV-2a. the mutation at position 264 has not been 
reported from India before. Furthermore, global phylogenetic analysis confirmed the molecular relationship of 
these new CPV-2a isolates with sequences from China. 
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Introduction 
Canine parvovirus type 2 (CPV-2) is a non-enveloped single stranded DNa virus (5.2 
kb), causing high mortality in young non-immune dogs aged from 6 weeks to 6 months 
(BaGShaW et al., 2014). the clinical signs include anorexia, fever, hemorrhagic diarrhea 
and fever. Canine parvovirus type 2 (CPV-2) is a type species of the genus Parvovirus that 
belongs to the family Parvoviridae under the sub-family Parvovirinae. CPV-2 was first 
identified in early 1978 as a pathogen causing acute hemorrhagic enteritis and leucopenia 
in young dogs (aPPeL et al., 2011). 
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Canine parvovirus-2 is believed to originate as a host range variant from the feline 
panleucopenia virus (FPLV), through a small number of mutations in the single VP2 gene 
(eLIa et al., 1979). Later, many other antigenic variants, such as CPV-2a (1980), CPV-2b 
(1984) and CPV- 2c (2000), began appearing in the canine population and replaced the 
original type 2 virus (trUYeN, 2006; PrateLLI et al., 2000; BUONaVOGLIa et al., 2001). 
amino acid substitutions at positions 87 (Met to Leu), 300 (ala to Gly) and 305 (asp 
to tyr) led to the evolution of 2 to 2a and substitution at 426 (asn to asp) and 555 (Ile 
to Val), giving rise to the emergence of 2b from 2a (SPIBeY et al., 2000). CPV-2c has a 
different amino acid, glutamic acid at position 426 compared to CPV-2b (MarteLLa et 
al., 2001). apart from these classical CPV-2 variants, many mutations, such as Ser297ala, 
thr440ala and tyr324Ile have been reported from India and all over the world (MIttaL 
et al., 2014; ChINChkar et al., 2006; DeCarO et al., 2006). Many authors have reported that 
canine parvovirus type 2a/2b having a mutation at 297 residue (Ser 297 ala) is designated 
as New CPV-2a/2b (DeCarO et al., 2006; OhShIMa et al., 2008; raJ et al., 2010).
the present study was aimed at sequencing of CPV-2 positive samples collected 
from the polyclinic of the Indian Veterinary Research Institute, and identification of 
any changes in the genetic composition of local isolates from its original prototype, by 
phylogenetic analysis.
Materials and methods
Selection of samples and oligonucleotide sequencing. as mentioned in our previous 
report (thOMaS et al., 2014), 23 dog fecal samples were confirmed to be positive for 
CPV-2 out of total 44 samples collected from diarrheic dogs presented to the veterinary 
polyclinic of the Indian Veterinary Research Institute, Bareilly. Bulk amplification of the 
randomly selected 15 PCr positive samples, targeting the partial VP2 gene was done 
as described previously (thOMaS et al., 2014) and 564 base pair products were purified 
using an Invitrogen Purelink PCR purification kit (Thermoscientific, Carlsban, USA), and 
custom sequenced using the primer pair CPV-PF/CPV-Pr.
Phylogenetic analysis. The specificity of the obtained sequences was determined using 
a Basic local alignment Search tool (BLaSt) and the further sequence chromatogram was 
visualized by Bioedit v 7.0.5 analysis software (Isis therapeutics, Carlsbad, Ca, USa) 
for proper alignment. all the sequences were aligned with the corresponding sequences 
available in the Gene Bank by the Clustal W (Mega5 software) method (taMUra et al., 
2011), by considering all the critical amino acid residues on the VP2 capsid protein (297, 
300, 305 and 426). the assembled sequences were also submitted to NCBI for allotment 
of accession numbers (http://www.ncbi.pubmed). the obtained sequence in this study 
and VP2 gene sequences of other reference CPV-2 variants from different geographical 
regions within India (eastern, western, southern and northern India) and the rest of the 
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world were retrieved from the NCBI nucleotide database (total number of retrieved 
sequences-81). Multiple sequence alignment was performed using the in-built ClustalW 
algorithm in MEGA6 software. Selection of the best-fit nucleotide substitution model 
for the data set confined to the partial VP2 gene (564 bp) was conducted in MEGA6. 
the evolutionary history was inferred using the Neighbor joining method, based on 
the p-distance model. The confidence level of branching in the phylogenetic tree was 
evaluated with the bootstrap test based on 2,000 resamplings. 
results 
a region over the VP2 gene, from nucleotide positions 772 to 1335 (amino acid 
positions from 258 to 445), was selected for bulk amplification using CPV-PF/CPV-PR 
primers, which yielded a specific 564 bp product, as described previously (thOMaS et al., 
2014). Amplified products of positive samples were sequenced and aligned by the Clustal 
W (Mega5 software) method. the assembled sequences were assigned by Gene Bank 
accession numbers from kJ-364526 (Be-3) and kM-003870 to kM003883 (Be-4 to Be-
17) and revealed that all the examined sequences significantly matched CPV-2a, with a 
maximum of 99% identity with the VP2 gene sequences of the reference strain (accession 
number = eU377537) available in the Gene Bank. Phylogenetic analyses of isolates with 
other Indian sequences and foreign sequences are depicted in Fig.1 and 2 respectively.
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Fig. 1. Neighbour joining tree depicting phylogenetic relationship between isolates of the present 
study with various CPV-2a isolates from different parts of India
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0.1Fig. 2. Neighbour joining tree depicting phylogenetic relationship between isolates of the present 
study with various CPV-2a isolates from India and other countries. the sequences in the present 
study are marked with bullet.
0.1
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Discussion 
The region selected for amplification contains 188 amino acids (564 nucleotides), 
which includes almost all informative amino acids responsible for generation of different 
antigenic variants reported so far. Thus, the amplification of the partial VP2 gene covering 
the key amino acids, using primers CPV-PF/CPV-Pr, and its oligonucleotide sequencing 
may be helpful in identification of CPV-2 variants. There are several methods available for 
the molecular characterization of CPV variants, however, PCR amplification of the VP2 
gene and subsequently oligonucleotide sequencing of the amplified product is considered 
to be a gold standard for identification of any antigenic or genetic differences between 
the original CPV-2 and its variants (NaNDI and kUMar, 2010). The finding of maximum 
prevalence of CPV-2a in India is contrary to another report (NaNDI et al., 2010) where it 
was reported that CPV-2b is the major antigenic variant in North India, especially in the 
Bareilly region. although some more samples from diverse sources should be examined 
before concluding that CPV-2a is now outpacing CPV-2b in this region, this seems to be 
the normal trend of distribution, as it has been demonstrated in some previous reports that 
CPV-2a is more common than CPV-2b in the Indian subcontinent (MUkhOPaDhYaY et 
al., 2014; ChINChkar et al., 2006).
CPV-2 regularly changes its genetic and antigenic character through frequent mutations 
in the VP2 gene, and the resulting variants (CPV 2a/b/c) are spreading throughout the 
world (NaNDI et al., 2009). In India, it has been reported that CPV-2a is the major antigenic 
variant of CPV-2, followed by CPV-2b (MUkhOPaDhYaY et al., 2014). recently MIttaL 
et al. (2014) reported some CPV-2a variants with amino acid mutations at positions 297 
(Ser297ala), 324 (Ile 324 tyr) and 440 (thr 440 ala). In the present work, we examined 
patterns of nucleotide sequences of 15 randomly selected samples out of 23 PCr positive 
samples available in the laboratory, and the sequencing data revealed Glycine at position 
300, tyrosine at 305 and asparagine at 426. this suggests that all the sequences are of the 
CPV-2a type. the amino acid residues at positions 87, 101 and 555 are unknown because 
these regions are not covered by the partial VP2 gene selected for PCR amplification. 
however, the deduced sequences of CPV-2 isolates in the present study showed some 
additional nucleotide substitution that resulted in the amino acid variations at positions 
264 (Gly264Val), 297 (Ser297ala) and 440 (thr440ala). the amino acid substitution 
at position 264 was observed only in 10 sequences because 20 to 30 nucleotides were 
missing from the 5’ end of the remaining 4 sequences due to a sequencing artifact, and 
there was no nucleotide substitution recorded in Be-3 isolates at this position. Both these 
mutations were also reported from China in 2011 (Gene accession number- JF681986.1). 
Mutation at 297 and 440 amino acid residues has already been reported in CPV-2a strains 
from India by MIttaL et al. (2014) and ChINChkar et al. (2006). however, the mutation 
at the 264 amino acid residue has not yet been reported in India. the greatest variability 
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among CPV isolates were detected in the Gh loop of the VP2 protein, particularly at 297, 
426, and 440 amino acid residue, and mutations at these regions are indicative of some 
new antigenic variants evolving in the circulating CPV types (ParrISh et al., 1991). the 
sequencing results in the present study reveal change at the 297 position of the VP2 capsid 
protein, which is essentially required for considering any isolates as a new CPV-2a/2b. 
Moreover the mutation at position 440 also has antigenic importance, as it is located in 
the Gh loop of the VP2 protein on the surface of the capsid (BattILaNI et al., 2002). the 
mutation at position 264 is very rare and has not been reported previously from India. It 
indicates that a new CPV-2a variant is spreading in this region with additional mutation 
at position 264 which has never been reported before. 
Sequence analysis of three vaccinated but PCr positive dog fecal samples (Be-11, 
Be-12, Be-14) shows that all are of the CPV-2a type, with a few additional synonymous 
mutations which exclude the possibility of the shedding of vaccine strains through feces 
in the current study, because none of the commercially available vaccines contains the 
CPV-2a strain in its formulation. hence, the reason for this vaccination failure may be 
either lack of a proper vaccine strain, improper dosing, or faulty administration.
Constructing the phylogenetic tree on the basis of deduced nucleotide sequences is 
an ideal way to find the origin and source of CPV-2. The amount of genetic change that 
occurred in the phylogenetic analysis of the isolates compared with other Indian sequences 
is 0.002, and with foreign sequences 0.05. this indicates that the genetic change between 
the Indian sequences is much less than when compared with foreign sequences. the 
VP2 gene is relatively constant and thus conclusions about separate lineages should be 
moderated. however, most of the new CPV-2a isolates, except Be-3 and Be-17, clustered 
in the same monophyletic clade in the Neighbor joining analysis at the region of the 
VP2 gene. Be-17 forms a separate lineage with other new CPV-2a isolates in the present 
study, while Be-3 forms a distinct lineage. this may be due to the presence of thymine 
at nucleotide position 3978 in both Be-3 and Be-17, instead of cytosine in other isolates, 
and there was no mutation recorded at position 264 in Be-3 when comparing with other 
isolates in the study. Be-3 and Be-17 show more similarity with sequences from north 
(Bareilly, Meerut), east (Odisha) and southern regions (andhra Pradesh, Chennai and 
Puducherry) of India than other isolates. all the isolates in the present study, especially 
Be-3 and Be-17, share common ancestral origin with sequences from China. hence, the 
isolates from the northern region of India used in the present study might have their origin 
in China, and this is similar to the findings observed by MUkhOPaDhYaY et al., (2014). 
Conclusion 
Despite regular vaccinations, CPV-2 infection is still a great threat to the canine 
population in India and across the world. the only way forward is to continuously 
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monitor the CPV-2 variants circulating in this region, which would be helpful in the 
identification of any major or minor changes occurring in the CPV-2 genome. Further 
work in this direction, involving samples from a large geographical area, may explore the 
present finding of CPV-2 variants which would be extremely useful in understanding the 
role of these variants in the pathogenesis of parvoviral disease in dogs, and formulating 
a suitable control strategy.
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Sažetak 
Infekcija pasjim parvovirusom 2 predstavlja ozbiljan problem uzrokujući veliki mortalitet u štenadi. 
Usprkos proširenom cijepljenju pasa, veliku poteškoću u kontroli ove smrtonosne bolesti predstavljaju različite 
antigenske varijante terenskih izolata virusa. Od bitnog je značenja redoviti nadzor i trajna kontrola tih varijanti 
koje mogu izbjeći imunski pritisak domaćina i otežati laboratorijsku dijagnostiku. Stoga ovo istraživanje ima 
za cilj rasvijetliti molekularnu epizootiologiju sojeva pasjeg parvovirusa 2 koji kolaju na sjevernom području 
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Indije. Uzorci pozitivni lančanom reakcijom polimerazom podvrgnuti su oligonukleotidnom sekvencioniranju. 
Ustanovljeno je da su ti izolati bili identični pasjem parvovirusu 2a, osim na mjestima aminokiselinskog 
ostatka 264, 297 i 440 što im upravo određuje pripadnost serotipu 2a. Mutacije na mjestu 264 dosada nisu bile 
opisane u Indiji. Globalnim filogenetskim analizama utvrđena je molekularna srodnost tih novih izolata pasjeg 
parvovirusa 2a s izolatima iz kine. 
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